Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $5.4700 (2.24%) ($5.2000 - $5.5100) on Wed. Dec. 4, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.44% (three month average) | RSI | 52 | Latest Price | $5.4700(2.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1% a day on average for past five trading days. | Weekly Trend | CGEN advances 1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) ARKG(66%) ARKK(63%) XBI(63%) IBB(57%) IPO(55%) | Factors Impacting CGEN price | CGEN will decline at least -1.72% in a week (0% probabilities). VXX(-37%) VIXM(-33%) UUP(-11%) TLT(-4%) SHY(-1%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.72% (StdDev 3.44%) | Hourly BBV | 0 () | Intraday Trend | 1.3% | | | |
|
Resistance Level | $5.64 | 5 Day Moving Average | $5.77(-5.2%) | 10 Day Moving Average | $5.73(-4.54%) | 20 Day Moving Average | $5.64(-3.01%) | To recent high | -10.2% | To recent low | 9.2% | Market Cap | $452m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |